<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59">
 <label>59</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hutson</surname>
    <given-names>P. H.</given-names>
   </name>
   <name>
    <surname>Finger</surname>
    <given-names>E. N.</given-names>
   </name>
   <name>
    <surname>Magliaro</surname>
    <given-names>B. C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</article-title>
  <source>
   <italic toggle="yes">Neuropharmacology</italic>
  </source>
  <year>2011</year>
  <volume>61</volume>
  <issue>4</issue>
  <fpage>665</fpage>
  <lpage>676</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.05.009</pub-id>
  <pub-id pub-id-type="other">2-s2.0-79959999316</pub-id>
  <?supplied-pmid 21619887?>
  <pub-id pub-id-type="pmid">21619887</pub-id>
 </element-citation>
</ref>
